Clinical Trial Update: To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of AZD7624 in healthy volunteers and patients with chronic obstructive pulmonary dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD7624

Snippet

Sponsor: AstraZeneca | Conditions: COPD, Healthy Subjects | Phase 1 | Status: COMPLETED | Results posted: 2016-03-30